ASCO Launches New Site to Seek Feedback From Cancer Community on Clinical Practice Guidelines
ASCO has launched a new wiki site to engage the cancer community in its clinical practice guideline development process. The new site will provide oncologists, practitioners, and patients with an opportunity to provide feedback or submit evidence on individual published guidelines.
“Cancer treatment has advanced based on clinical trials conducted in a surprisingly small number of patients. With new laboratory insights and a massive expansion of potential drugs, we have to begin to gain knowledge from every treatment experience if we are to accelerate progress and continuously improve quality of care,” said Clifford A. Hudis, MD, FACP, President of ASCO. “ASCO guidelines are intended to help improve cancer care and this new site will enhance our ability to do so by learning from the experiences of our colleagues,” Dr. Hudis said.
Share Comments, Provide Evidence
Individuals will have the opportunity to comment on published guidelines and provide new evidence, which will be reviewed by the site administrator and forwarded to the individual guideline panel co-chairs for consideration. In addition, the site will provide an overview of the evolution of the recommendations of each guideline.
All information is open for viewing. However, to comment or submit new evidence, an ASCO Guidelines Wiki user account is needed. To establish a user account, contact guidelines@asco.org.
ASCO published its first clinical practice guideline in 1994 and has since issued numerous guidelines on areas of care that range from prevention to treatment to quality of life. Guidelines can address specific clinical situations or the use of approved medical products, procedures, or tests. Using the best available evidence, ASCO expert panels identify and develop practice recommendations for specific areas of cancer care that would benefit from using practice guidelines. All ASCO Guidelines are published in the Journal of Clinical Oncology.
The content in this post has not been reviewed by the American Society of Clinical Oncology, Inc. (ASCO®) and does not necessarily reflect the ideas and opinions of ASCO®.
